IFN-αB Inhibitors
IFN-αB inhibitors represent a class of chemical compounds designed to specifically target and interfere with the activity of the IFN-αB gene or its encoded protein product. IFN-αB, short for Interferon-alpha B, is a member of the interferon family, a group of signaling proteins recognized for their essential roles in regulating the innate immune response to viral infections and other immune-related processes. These inhibitors are developed to modulate the function of IFN-αB, which may be involved in various cellular processes associated with antiviral defense, immunomodulation, and immune responses.
The primary mechanism of action for IFN-αB inhibitors typically involves their interaction with the IFN-αB protein or its associated molecules, leading to the disruption of its normal function. By inhibiting IFN-αB, these compounds have the potential to influence cellular processes related to antiviral defense, immune regulation, and the activation of immune cells. Researchers studying IFN-αB inhibitors aim to elucidate the specific roles of IFN-αB within the immune system, contributing to our understanding of its functions in the context of viral infections and immune responses. These inhibitors serve as valuable tools for advancing our knowledge of the intricate interplay between interferon signaling and the immune system. In this context, they play a significant role in furthering our understanding of immunology and antiviral research.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
Acetylsalicylic acid may suppress IFN-α gene expression by inhibiting cyclooxygenase and reducing prostaglandin synthesis. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone, a PPARγ agonist, may downregulate IFN-α expression through PPARγ-mediated signaling pathways. | ||||||
Apicidin | 183506-66-3 | sc-202061 sc-202061A | 1 mg 5 mg | $110.00 $343.00 | 9 | |
Apicidin, an HDAC inhibitor, could modify chromatin structure and decrease transcription of the IFN-α gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which may result in lower IFN-α production due to the mTOR pathway's role in protein synthesis. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could inhibit DNA methyltransferase, leading to DNA demethylation and potential suppression of IFN-α expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide may inhibit the transcription of various genes, which could include the genes encoding IFN-α. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is known to modulate several signaling pathways and may downregulate IFN-α expression through its effects on transcription factors. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane is suggested to influence NF-κB and Nrf2 pathways, potentially affecting IFN-α gene expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may interact with multiple signaling pathways, including SIRT1, which could impact IFN-α expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin has been shown to affect signaling pathways and may reduce IFN-α production as a part of its broad bioactivities. | ||||||